Patrones de prescripción de los nuevos anticoagulantes orales y sus costos económicos en Colombia
Tài liệu tham khảo
Ageno, 2012, Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest., 141, e44S, 10.1378/chest.11-2292
Wigle, 2013, Updated guidelines on outpatient anticoagulation, Am Fam Physician., 87, 556
Gutierrez, 2011, Atrial fibrillation: diagnosis and treatment, Am Fam Physician., 83, 61
Xu, 2012, Novel anticoagulants for non-valvular atrial fibrillation, Heart Lung Circ., 21, 463, 10.1016/j.hlc.2012.04.002
Potpara, 2013, Novel oral anticoagulants in non-valvular atrial fibrillation, Best Pract Res Clin Haematol., 26, 115, 10.1016/j.beha.2013.07.008
Kansal, 2013, Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation, Best Pract Res Clin Haematol., 26, 225, 10.1016/j.beha.2013.07.012
Riva, 2013, Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients, Thromb Res., 131, S67, 10.1016/S0049-3848(13)70026-4
Little, 2012, New oral anticoagulants: will they replace warfarin?, Oral Surg Oral Med Oral Pathol Oral Radiol, 113, 575, 10.1016/j.oooo.2011.10.006
Capodanno, 2013, Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients, Int J Cardiol., 167, 1237, 10.1016/j.ijcard.2012.03.148
O’Dell, 2012, New oral anticoagulants for atrial fibrillation: a review of clinical trials, Clin Ther, 34, 894, 10.1016/j.clinthera.2012.01.019
McManus, 2012, Thromboembolism, Am Fam Physician, 85, 188
Gómez-Outes, 2012, Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons, BMJ, 344, e3675, 10.1136/bmj.e3675
Falck-Ytter, 2012, Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest., 141, e278S, 10.1378/chest.11-2404
Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med., 365, 883, 10.1056/NEJMoa1009638
Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med., 361, 1139, 10.1056/NEJMoa0905561
Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med., 365, 981, 10.1056/NEJMoa1107039
Connolly, 2011, Apixaban in patients with atrial fibrillation, N Engl J Med., 364, 806, 10.1056/NEJMoa1007432
Marcus, 2010, European ancestry as a risk factor for atrial fibrillation in African Americans, Circulation., 122, 2009, 10.1161/CIRCULATIONAHA.110.958306
January, 2014, 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society, Circulation., 130, 2071, 10.1161/CIR.0000000000000040
Rao, 2014, Atrial fibrillation: a review of recent studies with a focus on those from the duke clinical research institute, Scientifica (Cairo)., 2014, 901586
Konstantinides, 2014, 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism, Eur Heart J., 35, 3033, 10.1093/eurheartj/ehu283
Albert, 2014, Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications, Heart Lung., 43, 48, 10.1016/j.hrtlng.2013.10.014
Gómez-Outes, 2013, Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups, Thrombosis., 2013, 640723, 10.1155/2013/640723
Levy, 2014, New oral anticoagulant-induced bleeding: clinical presentation and management, Clin Lab Med., 34, 575, 10.1016/j.cll.2014.06.004
Holster, 2013, New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis, Gastroenterology., 145, 10.1053/j.gastro.2013.02.041
Agnelli, 2013, New oral anticoagulants for the treatment of venous thromboembolism, Best Pract Res Clin Haematol., 151, 10.1016/j.beha.2013.07.005
Kang, 2014, Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism, Thromb Res., 133, 1145, 10.1016/j.thromres.2014.03.035
Kerr M. Cost and benefits of Antithrombotic therapy in atrial fibrilation in England: an economic analysis based on GRASP-AF. National Health System (NHS). 2014. fecha de consulta: abril 24 del 2015. Disponible en: http://www.nhsiq.nhs.uk/media/2566750/af_economic_analysis_final.pdf
Stefanini, 2013, Drug-eluting coronary-artery stents, N Engl J Med., 368, 254, 10.1056/NEJMra1210816
Huang, 2013, The efficacy and adverse reaction of bleeding of clopidogrel plus aspirin as compared to aspirin alone after stroke or TIA: a systematic review, PLoS One., 8, e65754, 10.1371/journal.pone.0065754
Hong, 2014, Dual antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack: pros and cons, J Clin Neurol., 10, 189, 10.3988/jcn.2014.10.3.189
Dewilde, 2014, Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review, J Am Coll Cardiol., 64, 1270, 10.1016/j.jacc.2014.06.1193
Dzeshka, 2014, Anticoagulant Therapy for Atrial Fibrillation, Cardiol Clin., 32, 585, 10.1016/j.ccl.2014.07.009
Guérin, 2013, Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy, Int J Cardiol., 167, 564, 10.1016/j.ijcard.2012.01.047
Gorczyca-Michta, 2013, Prevalence and predisposing conditions for atrial fibrillation in hospitalised patients with hypertension, Kardiol Pol., 71, 352, 10.5603/KP.2013.0062
Vyssoulis, 2013, Metabolic syndrome and atrial fibrillation in patients with essential hypertension, Nutr Metab Cardiovasc Dis., 23, 109, 10.1016/j.numecd.2011.03.011
Jiří Widimský, 2012, Arterial hypertension and atrial fibrillation: Selecting antihypertensive therapy, Cor et Vasa., 54, e248, 10.1016/j.crvasa.2012.08.004
Lane, 2012, Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation, Circulation., 126, 860, 10.1161/CIRCULATIONAHA.111.060061
Koju, 2014, Association of cardiovascular risk factors and coronary artery lesion among coronary artery disease patients, Kathmandu Univ Med J (KUMJ)., 12, 137
Aristizábal, 2012, Consideraciones prácticas para el uso de los nuevos anticoagulantes orales, Rev Colomb Cardiol., 19, 135
Machado-Alba, 2008, Prescription patterns for antilipidemic drugs in a group of Colombian patients, Rev Panam Salud Publica., 23, 179